Reduced 5-methylcytosine level as a potential progression predictor in patients with T1 or non-invasive urothelial carcinoma. [electronic resource]
- International journal of molecular sciences Dec 2014
- 677-90 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1422-0067
10.3390/ijms16010677 doi
5-Methylcytosine--metabolism Adult Aged Aged, 80 and over Carcinoma--metabolism DNA (Cytosine-5-)-Methyltransferase 1 DNA (Cytosine-5-)-Methyltransferases--metabolism DNA Methylation Female Humans Immunohistochemistry Male Middle Aged Neoplasm Staging Odds Ratio Urologic Neoplasms--metabolism Urothelium--metabolism